Bafna Pharmaceuticals Limited (BAFNAPH.NS) NSE

172.40

+7.39(+4.48%)

Updated at December 24 03:29PM

Currency In INR

Valuation

Market Cap1.77B
Enterprise Value2.02B
P/E Ratio46.52
PEG Ratio7.73
Price/Sales Ratio2.87
Price/Book Ratio4.47
Enterprise/Revenue3.09
Enterprise/EBITDA26.33

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.06
Operating Margin0.08

Management Effectiveness

Return On Assets0.05
Return On Equity0.1

Income Statement

Revenue1.46B
Revenue/Share60.13
Gross Profit168.77M
EBITDA117.74M
Net Income41.53M
Diluted EPS1.76

Balance Sheet

Total Cash19.67M
Total Cash/Share0.83
Total Debt324.03M
Total Debt/Equity0.36
Current Ratio1.67
Book Value Per Share38.54

Price History

52-Week Change117.65
52-Week High202.06
52-Week Low69
Moving Average 50 Days154.28
Moving Average 200 Days108.41

Statistics

Average Volume7,415
Shares Outstanding23.66M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateAugust 26, 2019